Links between gut microbiota and metabolic diseases have been suggested for many years, but results of studies in human beings and animals are conflicting. Bryant Furlow discusses new research in this area as a new study shows that promoting growth of bifidobacteria reduces risk factors for metabolic syndrome.
The interactions between gut microbial communities, obesity, and human health are complex, and researchers have only begun to thoroughly describe and disentangle them, experts tell The Lancet Diabetes & Endocrinology. The evidence base for therapeutic strategies based on manipulation of the microbiome is still largely descriptive and preclinical, they caution. But a new clinical study offers reason for cautious optimism that manipulating the microbiome’s composition in bifidobacteria’s favour just might help reduce physiological risk factors for metabolic syndrome in overweight adults.
Date Published: January 2013